Skip to main content
BALAXI PHARMACEUTICALS LIMITED logo

BALAXI PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · BALAXI ISIN · INE618N01022 LEI · 894500VRENAYIIWHHQ13 National Stock Exchange of India Wholesale and retail trade
Open in API
Filings indexed 614 across all filing types
Latest filing 2026-03-26 Regulatory Filings
Country IN India
Listing National Stock Exchange of India BALAXI

About BALAXI PHARMACEUTICALS LIMITED

https://www.balaxipharma.in/

Balaxi Pharmaceuticals Limited is a specialty pharmaceutical company that operates an asset-light business model focused on sourcing, branding, and distributing generic formulations in frontier markets. The company primarily serves emerging economies across Africa and Latin America, including Angola, Guatemala, and the Dominican Republic. Its product portfolio encompasses a wide range of therapeutic segments such as anti-infectives, analgesics, and antimalarials. Balaxi manages an integrated supply chain, leveraging its regulatory expertise to register and market high-quality pharmaceutical products. By maintaining a robust distribution network and localized presence, the company ensures the availability of essential medicines in underserved regions while optimizing operational efficiency through its specialized procurement and logistics framework.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange's listing department, notifying the closure of the trading window in compliance with insider trading regulations. It mentions the upcoming declaration of audited financial results for the quarter and fiscal year ending March 31, 2026, but does not contain any financial data or results itself. The document is short (1425 characters) and serves as an announcement related to regulatory compliance and trading restrictions rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which covers miscellaneous regulatory announcements that do not fit other categories.
2026-03-26 English
Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the authorization of key managerial personnel to determine the materiality of events for disclosure purposes under SEBI Listing Regulations. It references Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content is about management authorization and compliance disclosure rather than financial results, audit, or report publication. The document length is short (2216 characters) and does not contain financial data or detailed report content. It is an announcement related to management roles and regulatory compliance disclosures. Therefore, it fits best under Board/Management Information (MANG).
2026-03-25 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the outcome of a Board Meeting held on March 25, 2026. The key content is the appointment of a new Company Secretary and Compliance Officer, Mr. Aman Purohit, effective from the same date. The document includes details required under a SEBI Master Circular, which is a regulatory compliance requirement. There are no financial statements, earnings data, or detailed management discussion and analysis. The document is an announcement of a board decision regarding management changes, specifically the appointment of a senior officer. This fits the category of Board/Management Information (MANG). The document length is 3224 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2026-03-25 English
Change in Management
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the outcome of a Board Meeting held on March 25, 2026. The key content is the appointment of a new Company Secretary and Compliance Officer, Mr. Aman Purohit, effective from the same date. The document includes details required under a SEBI Master Circular related to this appointment. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement of a board decision regarding management changes, specifically the appointment of a senior officer. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3224 characters, which is relatively short and focused on management change, not a report or announcement of a report publication.
2026-03-25 English
Change in Company Secretary/Compliance Officer
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the outcome of a Board Meeting held on March 25, 2026. The key content is the appointment of a new Company Secretary and Compliance Officer, Mr. Aman Purohit, including his profile and details as required by SEBI regulations. There is no financial data, earnings information, or report publication mentioned. The document focuses on a change in senior management personnel, which fits the category of Board/Management Information (MANG). The document length is 3224 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the appropriate classification is MANG with high confidence.
2026-03-25 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited, informing about the outcome of a Board Meeting held on March 25, 2026. The key content is the appointment of a new Company Secretary and Compliance Officer, Mr. Aman Purohit, effective from the same date. The document includes details required under a SEBI Master Circular related to this appointment. There are no financial statements, earnings data, or detailed management discussion. The document is an announcement of a board decision regarding management changes, specifically the appointment of a senior officer. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3224 characters, which is relatively short and consistent with an announcement rather than a full report.
2026-03-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.